Erratum: Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy (American Journal of Respiratory and Critical Care Medicine (2017) 195 (331-338) DOI: 10.1164/rccm.201603-0645OC);Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy

American Journal of Respiratory and Critical Care Medicine

Volumn 195, Issue 3, 2017, Pages 331-338

  Famous, Katie R ^a   Delucchi, Kevin ^b   Ware, Lorraine B ^b,f   Kangelaris, Kirsten N ^c   Liu, Kathleen D ^d,e   Thompson, B Taylor ^g   Calfee, Carolyn S ^a,e  

^a Division of Pulmonary and Critical Care Medicine   (United States)

^b Department of Psychiatry ^*  (United States)

^c Division of Hospital Medicine   (United States)

^d Division of Nephrology   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f VANDERBILT UNIVERSITY   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Acute lung injury; Fluid therapy; Subphenotype

Indexed keywords

BICARBONATE; BIOLOGICAL MARKER; CREATININE; HYPERTENSIVE AGENT; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTERIAL OXYGEN SATURATION; ARTICLE; ASPIRATION; CENTRAL VENOUS PRESSURE; CLINICAL OUTCOME; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; FLUID RESUSCITATION; HEART RATE; HUMAN; HYPOTENSION; INFLAMMATION; INJURY; LUNG MINUTE VOLUME; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; BLOOD; CLASSIFICATION; FLUID THERAPY; PHENOTYPE; POSITIVE END EXPIRATORY PRESSURE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY DISTRESS SYNDROME, ADULT; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

BIOMARKERS; FEMALE; FLUID THERAPY; HUMANS; LOGISTIC MODELS; MALE; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PHENOTYPE; POSITIVE-PRESSURE RESPIRATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 85014772016     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.v198erratum5     Document Type: Erratum

References (18)

1. Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest 2012;122:2731-2740.
2. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-1308.
3. Calfee CS, Delucchi K, Parsons PE, Thompson BT, Ware LB, Matthay MA; NHLBI ARDS Network. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med 2014;2:611-620.
4. Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, Schoenfeld D, Thompson BT; National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004;351: 327-336.
5. Ware LB, Eisner MD, Thompson BT, Parsons PE, Matthay MA. Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med 2004;170: 766-772.
6. Walter JM, Wilson J, Ware LB. Biomarkers in acute respiratory distress syndrome: from pathobiology to improving patient care. Expert Rev Respir Med 2014;8:573-586.
7. Famous KR, Delucchi K, Ware LB, Liu K, Kangelaris KN, Thompson BT, Matthay M, Calfee CS. Is a fluid-conservative strategy optimal for all patients with acute respiratory distress syndrome (ARDS)? Latent class analysis indicates that ARDS endotypes have a differential response to fluid-management strategy in the NHLBI ARDS Network Fluid and Catheter Treatment Trial (FACTT) [abstract]. Am J Respir Crit Care Med 2016;193:A6445.
8. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF Jr, Hite RD, Harabin AL; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluidmanagement strategies in acute lung injury. N Engl JMed 2006;354: 2564-2575.
9. Wheeler AP, Bernard GR, Thompson BT, Schoenfeld D, Wiedemann HP, deBoisblanc B, Connors AF Jr, Hite RD, Harabin AL; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med 2006;354:2213-2224.
10. Hagenaars JA, McCutcheon AL. Applied latent class analysis. New York: Cambridge University Press; 2002.
11. McLachlan G, Peel D. Finite mixture models. New York: John Wiley & Sons, Inc; 2000.
12. Calfee CS, Gallagher D, Abbott J, Thompson BT, Matthay MA, Network NA; NHLBI ARDS Network. Plasma angiopoietin-2 in clinical acute lung injury: prognostic and pathogenetic significance. Crit Care Med 2012;40:1731-1737.
13. Calfee CS, Janz DR, Bernard GR, May AK, Kangelaris KN, Matthay MA, Ware LB; NIH NHLBI ARDS Network. Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies. Chest 2015;147:1539-1548.
14. Agrawal A, Matthay MA, Kangelaris KN, Stein J, Chu JC, Imp BM, Cortez A, Abbott J, Liu KD, Calfee CS. Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients. Am J Respir Crit Care Med 2013;187:736-742.
15. Bhandari V, Choo-Wing R, Lee CG, Zhu Z, Nedrelow JH, Chupp GL, Zhang X, Matthay MA, Ware LB, Homer RJ, et al. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med 2006;12:1286-1293.
16. Briot R, Frank JA, Uchida T, Lee JW, Calfee CS, Matthay MA. Elevated levels of the receptor for advanced glycation end products, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fluid clearance in isolated perfused human lungs. Chest 2009;135:269-275.
17. Wilson JG, Matthay MA. Mechanical ventilation in acute hypoxemic respiratory failure: a review of new strategies for the practicing hospitalist. J Hosp Med 2014;9:469-475.
18. Iwashyna TJ, Burke JF, Sussman JB, Prescott HC, Hayward RA, Angus DC. Implications of heterogeneity of treatment effect for reporting and analysis of randomized trials in critical care. Am J Respir Crit Care Med 2015;192:1045-1051.